Journal of Surgery Concepts & Practice ›› 2022, Vol. 27 ›› Issue (05): 385-386.doi: 10.16139/j.1007-9610.2022.05.001
• Editorial • Next Articles
CHEN Xiaosong, SHEN Kunwei(
), Ll Hongwei
Received:2022-09-09
Online:2022-09-25
Published:2022-11-10
Contact:
SHEN Kunwei
E-mail:kwshen@medmail.com.cn
CLC Number:
CHEN Xiaosong, SHEN Kunwei, Ll Hongwei. Diagnosis and treatment in early operable breast cancer: current status and prospect[J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 385-386.
| [1] | Loibl S, Poortmans P, Morrow M, et al. Breast cancer[J]. Lancet, 2021, 397(10286):1750-1769. |
| [2] | Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs. no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial[J]. JAMA, 2017, 318(10): 918-926. |
| [3] | Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases(IBCSG 23-01):10-year follow-up of a randomised, controlled phase 3 trial[J]. Lancet Oncol, 2018, 19(10):1385-1393. |
| [4] | Simons JM, van der Pol CC, et al. Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer[J]. JAMA Surg, 2022, e223907. |
| [5] | Masuda N, Lee S, Ohtani S, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy[J]. N Engl J Med, 2017, 376(22):2147-2159. |
| [6] | von Minckwitz G, Huang CS, Mano MS, et al. Trastuzu-mab emtansine for residual invasive HER2-positive breast cancer[J]. N Engl J Med, 2019, 380(7):617-628. |
| [7] | Schmid P, Cortes J, Dent R, et al. Event-free survival with pembrolizumab in early triple-negative breast cancer[J]. N Engl J Med, 2022, 386(6):556-567. |
| [8] | Tutt AN, Garber JE, Kaufman B, et al. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer[J]. N Engl J Med, 2021, 384(25):2394-2405. |
| [9] | Harbeck N, Rastogi P, Martin M, et al. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study[J]. Ann Oncol, 2021, 32(12):1571-1581. |
| [10] | Mateo J, Steuten L, Aftimos P, et al. Delivering precision oncology to patients with cancer[J]. Nat Med, 2022, 28(4):658-665. |
| [1] | ZHU Qiaoli, MIAO Yiming, CHEN Xiaosong. Prognostic analysis of breast-conserving surgery or mastectomy in patients with stage Ⅰ-Ⅲ triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 371-377. |
| [2] | YANG Yi, YANG Xingxia, JIN Sili, ZHANG Xu, ZHU Juanying, CHEN Xiaosong. Clinical application of preoperative MRI examination in breast-conserving surgery for ductal carcinoma in situ [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 378-382. |
| [3] | DONG Jun, CUI Fengming, LIU Jun. Effects of silencing Ki-67 gene on doxorubicin resistance of breast cancer MCF-7/DOX cells [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 254-259. |
| [4] | GAO Weiqi, ZHANG Xu, WANG Zheng, ZHU Yifei, HUANG Jiahui, HONG Jin, ZHU Siji, CHEN Xiaosong, HUANG Ou, HE Jianrong, CHEN Weiguo, LI Yafen, SHEN Kunwei, XU Hua, WU Jiayi. Safety analysis of immediate breast reconstruction with deep inferior epigastric perforator after neoadjuvant treatment [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 147-151. |
| [5] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 387-391. |
| [6] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 392-395. |
| [7] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 396-402. |
| [8] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 403-405. |
| [9] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 406-410. |
| [10] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 411-415. |
| [11] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 416-420. |
| [12] | YANG Cuiyan, WANG Haoyu, CHEN Xiaosong, SHEN Kunwei. Study on tumour suppressor gene TP53 mutation and prognosis in patients with triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 421-428. |
| [13] | PAN Ruixin, CHEN Xiaosong, SHEN Kunwei. Study on circulating tumor DNA and circulating tumor cell detecting minimal residual disease in breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 463-467. |
| [14] | ZHU Siyi, CHEN Xiaosong, SHEN Kunwei. Study on obesity associated with prognosis of early breast cancer and efficacy of adjuvant therapy [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 468-472. |
| [15] | WANG Jieqiang, MA Dekui. Study on trophoblast cell-surface antigen 2 gene and triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 473-477. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
